Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment ... for people living with hemophilia. In April, the FDA approved Pfizer’s Beqvez, a one-time gene therapy for ...

the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later, the Pfizer treatment ...

Related FDA approves new drug to treat protein buildup in the heart FDA approves first once-weekly drug treatment regimen for hemophilia ... At 1:30 p.m., Pfizer's stock was down 2 cents to ...

Qfitlia is the second RNA interference drug to score a highly anticipated FDA nod in recent ... most recently approved hemophilia drugs—Novo Nordisk’s Alhemo and Pfizer’s Hympavzi.